A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18
- 1 July 2002
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 60 (1) , 16-24
- https://doi.org/10.1034/j.1399-0039.2002.600103.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytesTissue Antigens, 2001
- A newly identifiedMAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytesInternational Journal of Cancer, 1999
- The Multi-epitope Approach for Immunotherapy for Cancer: Identification of Several CTL Epitopes from Various Tumor-Associated Antigens Expressed on Solid Epithelial TumorsHuman Immunology, 1998
- Two Members of the HumanMAGEBGene Family Located in Xp21.3 Are Expressed in Tumors of Various Histological OriginsGenomics, 1997
- A peptide encoded by the human MAGE3 gene and presented by HLA-1344 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3Immunogenetics, 1996
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.The Journal of Experimental Medicine, 1994
- Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.The Journal of Experimental Medicine, 1987
- Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodiesTissue Antigens, 1983
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977